<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2023_2_39</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-163</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>АНАЛИЗ СТРУКТУРЫ ОСЛОЖНЕНИЙ НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИИ  У УМЕРШИХ ПАЦИЕНТОВ</article-title><trans-title-group xml:lang="en"><trans-title>ANALYSIS OF THE STRUCTURE OF COMPLICATIONS OF A NEW CORONAVIRUS  INFECTION IN PATIENTS WHO HAVE DIED</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дац</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dats</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>664049, г. Иркутск, м/р Юбилейный, 100 </p></bio><bio xml:lang="en"><p>Yubileyny microdistrict, Irkutsk, 664049</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дац</surname><given-names>Л. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Dats</surname><given-names>S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>664049, г. Иркутск, м/р Юбилейный, 100 </p></bio><bio xml:lang="en"><p>Yubileyny microdistrict, Irkutsk, 664049</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутская государственная медицинская академия последипломного образования - филиал Федеральное государственное бюджетное образовательное учреждение &#13;
дополнительного профессионального образования «Российская медицинская академия непрерывного профессионального образования» Минздрава РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of  Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>05</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>39</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дац А.В., Дац Л.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Дац А.В., Дац Л.С.</copyright-holder><copyright-holder xml:lang="en">Dats A.V., Дац Л.С.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/163">https://www.zabmedvestnik.ru/jour/article/view/163</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Изучить частоту и виды осложнений у пациентов, умерших от новой коронавирусной инфекции (COVID-19). </p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено ретроспективное исследование медицинских карт стационарных больных и экспертиз качества медицинской помощи 61 пациента с тяжелым и крайне-тяжелым течением COVID-19, умерших в больницах Иркутской области в период с 1 января 2021 по 31 декабря 2021. В исследование включены пациенты в возрасте старше 18 лет с положительным результатом лабораторного исследования на наличие РНК SARS-CoV-2. Исключены из исследования пациенты с невыполнением, несвоевременным или ненадлежащим выполнением необходимых пациенту диагностических мероприятий; с невыполнением обязательного патологоанатомического вскрытия; с наличием признаков искажения сведений о проведенных диагностических и лечебных мероприятиях.  </p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что наиболее частым осложнением у умерших пациентов от новой коронавирусной инфекции (COVID-19), была пневмония, затем следовали отек головного мозга, сепсис, госпитальное острое почечное повреждение, метаболический ацидоз, острое повреждение миокарда, респираторный ацидоз, аритмии, перегрузка жидкостью, острое нарушение мозгового кровообращения, тромбэмболия легочной артерии, острая сердечная недостаточность, реже регистрировались диссеминированное внутрисосудистое свертывание крови и делирий. </p><p>Причинами метаболического ацидоза в большинстве случаев были сепсис и острое почечное повреждение, а респираторного ацидоза – острый респираторный дистресс-синдром.  </p></sec><sec><title>Заключение</title><p>Заключение. Новая коронавирусная инфекция (COVID-19) вызывает повреждения легких, головного мозга, сердца и почек, которые обуславливают тяжесть состояния пациентов и приводят к летальным исходам.  </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The aim of the research</title><p>The aim of the research: To study the frequency and types of complications in patients who have died from the novel coronavirus infection (COVID-19).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A retrospective study of medical records of inpatients and examinations of the quality of medical care of 61 patients with severe and extremely severe COVID-19 who died in hospitals of the Irkutsk region in the period from January 1, 2021 to December 31, 2021 was conducted.</p><p>The study included patients over the age of 18 years with a positive laboratory result for the presence of SARSCoV-2 RNA. Patients with non-fulfillment, untimely or improper implementation of the diagnostic measures necessary for the patient are excluded from the study; failure to perform a mandatory post-mortem examination; with the presence of signs of distortion of information about the diagnostic and therapeutic measures taken.</p></sec><sec><title>The results</title><p>The results. Pneumonia complicated by acute respiratory distress syndrome was the most common complication, in deceased patients from the novel coronavirus infection COVID-19 followed by cerebral edema, sepsis, hospital acute kidney injury, metabolic acidosis, acute myocardial damage, respiratory acidosis, arrhythmias, fluid overload, аcute cerebrovascular accident, pulmonary thromboembolism, acute heart failure, less often disseminated intravascular coagulation and delirium were recorded.</p><p>The causes of metabolic acidosis in most cases were sepsis and acute kidney injury, and respiratory acidosis - acute respiratory distress syndrome.</p></sec><sec><title>Conclusion</title><p>Conclusion. The novel coronavirus infection COVID-19 causes damage to the lungs, brain, heart and kidneys, which causes the severity of the patient's condition and leads to death.  </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>новая коронавирусная инфекция</kwd><kwd>COVID-19</kwd><kwd>осложнения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>novel coronavirus infection</kwd><kwd>COVID-19</kwd><kwd>complications</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Poorolajal J. The global pandemics are getting more frequent and severe. J of Research in Health Sciences. 2021. 21(1). e00502. doi:10.34172/jrhs.2021.40. - PMID 34024760.</mixed-citation><mixed-citation xml:lang="en">Poorolajal J. The global pandemics are getting more frequent and severe. J of Research in Health Sciences. 2021. 21(1). e00502. doi:10.34172/jrhs.2021.40. - PMID 34024760.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. Johns Hopkins University. Дата обращения: 31 января 2023.</mixed-citation><mixed-citation xml:lang="en">COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). ArcGIS. Johns Hopkins University. Дата обращения: 31 января 2023.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. S0140-6736(20)305663. doi:10.1016/S0140-6736(20)30566-3.</mixed-citation><mixed-citation xml:lang="en">Zhou F., Yu T.,  Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. S0140-6736(20)305663. doi:10.1016/S0140-6736(20)30566-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. doi:10.1007/s00134-020-05991-x.</mixed-citation><mixed-citation xml:lang="en">Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. doi:10.1007/s00134-020-05991-x.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shi S., Qin M., Shen B. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020. 5 (7). 802-810. doi:10.1001/jamacardio.2020.0950.</mixed-citation><mixed-citation xml:lang="en">Shi S., Qin M., Shen B. et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020. 5(7). 802-810. doi:10.1001/jamacardio.2020.0950.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pellicori P., Doolub G., Wong C.M. et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst. Rev. 2021. 3 (3). CD013879. doi: 10.1002/14651858.CD013879.PMID: 33704775</mixed-citation><mixed-citation xml:lang="en">Pellicori P., Doolub G., Wong C.M. et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst. Rev. 2021. 3(3). CD013879. doi: 10.1002/14651858.CD013879.PMID: 33704775</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pathophysiology of Cardiovascular Complications in COVID-19 https://www.frontiersin.org/articles/10.3389/fphys.2020.575600/full.</mixed-citation><mixed-citation xml:lang="en">Pathophysiology of Cardiovascular Complications in COVID-19 https://www.frontiersin.org/articles/10.3389/fphys.2020.575600/full.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny О. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. 5(7). 831-40.</mixed-citation><mixed-citation xml:lang="en">Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny О. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. 5(7). 831-40.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Liu P.P., Blet A., Smyth D., Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020. 142(1). 68-78.</mixed-citation><mixed-citation xml:lang="en">Liu P.P., Blet A., Smyth D., Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020. 142(1). 68-78.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Raina R., Mahajan Z.A., Vasistha P. et al. Incidence and outcomes of acute kidney injury in COVID-19: a systematic review. Blood Purif. 2021. 15. 1-14.</mixed-citation><mixed-citation xml:lang="en">Raina R., Mahajan Z.A., Vasistha P. et al. Incidence and outcomes of acute kidney injury in COVID-19: a systematic review. Blood Purif. 2021. 15. 1-14.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Acute respiratory distress syndrome: The Berlin definition. JAMA – J Am Med Assoc. 2012. 307 (23). 2526-2533.</mixed-citation><mixed-citation xml:lang="en">Acute respiratory distress syndrome: The Berlin definition. JAMA – J Am Med Assoc. 2012. 307(23). 2526-2533.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)» Версия 10 (08.02.2021). https://3quality.ru/blog/medical_workers/interim_guidelines_v10/.</mixed-citation><mixed-citation xml:lang="en">Temporary Methodical Recommendations of the Russian Ministry of Health "Prevention, Diagnosis and Treatment of New Coronavirus Infection (COVID-19)" Version 10 (08.02.2021). URL: https://3quality.ru/blog/medical_workers/interim_guidelines_v10/. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Временные методические рекомендации Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)» Версия 11 (07.05.2021). https://minzdrav.gov.ru/news/2021/05/07/16568-minzdrav-rossii-vypustil-novuyu-versiyumetodrekomendatsiy-po-koronavirusu.</mixed-citation><mixed-citation xml:lang="en">Temporary Methodical Recommendations of the Russian Ministry of Health "Prevention, Diagnosis and Treatment of New Coronavirus Infection (COVID-19)" Version 11 (07.05.2021). URL: https://minzdrav.gov.ru/news/2021/05/07/16568-minzdrav-rossii-vypustil-novuyu-versiyumetodrekomendatsiy-po-koronavirusu. in Russian.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Singer M., Deutschman C.S., Seymour C.W. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016. 315(8). 801-10.</mixed-citation><mixed-citation xml:lang="en">Singer M., Deutschman C.S., Seymour C.W. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016. 315(8). 801-10.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl. 2012. 2 (1). 1138. DOI: 10.1038/kisup.2011.37.</mixed-citation><mixed-citation xml:lang="en">Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. Suppl. 2012. 2 (1). 1138. DOI: 10.1038/kisup.2011.37.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 rapid guideline: Managing COVID-19, v28.0 published on 29/03/2023 https://app.magicapp.org/#/guideline/6897.</mixed-citation><mixed-citation xml:lang="en">COVID-19 rapid guideline: Managing COVID-19, v28.0 published on 29/03/2023 https://app.magicapp.org/#/guideline/6897.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology, European Heart J. 2005. 26(4). 384-416, https://doi.org/10.1093/eurheartj/ehi044.</mixed-citation><mixed-citation xml:lang="en">Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology, European Heart J. 2005. 26(4). 384-416, https://doi.org/10.1093/eurheartj/ehi044.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001. 86. 1327-30.</mixed-citation><mixed-citation xml:lang="en">Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001. 86. 1327-30.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Deng Y., Liu W., Liu K. et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J 2020. 133. 1261–1267. doi: 10.1097/CM9.0000000000000824.</mixed-citation><mixed-citation xml:lang="en">Deng Y., Liu W., Liu K. et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J 2020. 133. 1261–1267. doi: 10.1097/CM9.0000000000000824.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chen T., Wu D., Chen H. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020. 368. m1091. doi: https://doi.org/10.1136/bmj.m1091.</mixed-citation><mixed-citation xml:lang="en">Chen T., Wu D., Chen H. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020. 368. m1091. doi: https://doi.org/10.1136/bmj.m1091</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
